Found: 27
Select item for more details and to access through your institution.
Editorial: Reviews in opioid use disorders.
- Published in:
- Frontiers in Public Health, 2024, p. 1, doi. 10.3389/fpubh.2024.1467826
- By:
- Publication type:
- Article
Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 3, p. 245, doi. 10.1007/s40261-021-01009-6
- By:
- Publication type:
- Article
Authors' Reply to Bonnet et al. "Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update".
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update.
- Published in:
- Drugs, 2021, v. 81, n. 1, p. 125, doi. 10.1007/s40265-020-01432-7
- By:
- Publication type:
- Article
Reply to Letter to the Editor Regarding Article: "Considering the Potential Benefits of Over-The-Counter Naloxone" [Response To Letter].
- Published in:
- Integrated Pharmacy Research & Practice, 2021, v. 10, p. 77, doi. 10.2147/IPRP.S327403
- By:
- Publication type:
- Article
Considering the Potential Benefits of Over-the-Counter Naloxone.
- Published in:
- Integrated Pharmacy Research & Practice, 2021, v. 10, p. 13, doi. 10.2147/IPRP.S244709
- By:
- Publication type:
- Article
Pimavanserin: A Novel Drug Approved to Treat Parkinson's Disease Psychosis.
- Published in:
- Innovations in Clinical Neuroscience, 2018, v. 15, n. 1/2, p. 16
- By:
- Publication type:
- Article
Receipt of Substance Use Counseling Among Ambulatory Patients Prescribed Opioids in the United States.
- Published in:
- Substance Abuse: Research & Treatment, 2020, v. 14, p. 1, doi. 10.1177/1178221819894588
- By:
- Publication type:
- Article
Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics.
- Published in:
- Substance Abuse: Research & Treatment, 2019, v. 13, p. N.PAG, doi. 10.1177/1178221819844205
- By:
- Publication type:
- Article
Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics.
- Published in:
- Substance Abuse: Research & Treatment, 2019, v. 13, p. N.PAG, doi. 10.1177/1178221819844205
- By:
- Publication type:
- Article
Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?
- Published in:
- Substance Abuse: Research & Treatment, 2018, v. 12, p. 1, doi. 10.1177/1178221818801311
- By:
- Publication type:
- Article
Naloxone Accessibility Without a Prescriber Encounter Under Standing Orders at Community Pharmacy Chains in Texas.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Implementing mentoring into a pharmacy teaching and learning curriculum.
- Published in:
- American Journal of Health-System Pharmacy, 2015, v. 72, n. 11, p. 906, doi. 10.2146/ajhp140873
- By:
- Publication type:
- Article
Association of Gabapentinoids With Opioid-Related Overdose in the Inpatient Setting: A Single Center Retrospective Case-Control Study.
- Published in:
- Hospital Pharmacy, 2024, v. 59, n. 2, p. 188, doi. 10.1177/00185787231206522
- By:
- Publication type:
- Article
Research and scholarly methods: Audit studies.
- Published in:
- JACCP: Journal of the American College of Clinical Pharmacy, 2023, v. 6, n. 5, p. 521, doi. 10.1002/jac5.1782
- By:
- Publication type:
- Article
Predictors of Gabapentin Overuse With or Without Concomitant Opioids in a Commercially Insured U.S. Population.
- Published in:
- Pharmacotherapy, 2018, v. 38, n. 4, p. 436, doi. 10.1002/phar.2096
- By:
- Publication type:
- Article
Stop the Bleed: An Interprofessional Community Service Learning Project Assessing the Efficacy of Pharmacist-Led Hemorrhage Control Education for Laypersons.
- Published in:
- Disaster Medicine & Public Health Preparedness, 2021, v. 15, n. 3, p. 271, doi. 10.1017/dmp.2020.8
- By:
- Publication type:
- Article
Gabapentinoid Pharmacology in the Context of Emerging Misuse Liability.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, p. S89, doi. 10.1002/jcph.1833
- By:
- Publication type:
- Article
Suvorexant: A Dual Orexin Receptor Antagonist for the Treatment of Sleep Onset and Sleep Maintenance Insomnia.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 4, p. 477, doi. 10.1177/1060028015570467
- By:
- Publication type:
- Article
Retrospective Cohort Evaluating the Comparative Effectiveness of Ceftaroline and Daptomycin as First-Line Therapies for Inpatient Treatment of Diabetic Foot Infection in the United States Veterans Health Care System.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 609, doi. 10.1007/s40801-022-00319-1
- By:
- Publication type:
- Article
Ranibizumab: The First Vascular Endothelial Growth Factor Inhibitor Approved for the Treatment of Diabetic Macular Edema.
- Published in:
- Annals of Pharmacotherapy, 2013, v. 47, n. 6, p. 811, doi. 10.1345/aph.1S013
- By:
- Publication type:
- Article
Aflibercept: Newly Approved for the Treatment of Macular Edema Following Central Retinal Vein Occlusion.
- Published in:
- Annals of Pharmacotherapy, 2013, v. 47, n. 6, p. 819, doi. 10.1345/aph.1R705
- By:
- Publication type:
- Article
Letter to the Editor: Comment on "Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth".
- Published in:
- 2021
- By:
- Publication type:
- Letter
Kratom as a potential substance use disorder harm reduction agent.
- Published in:
- Frontiers in Public Health, 2024, p. 1, doi. 10.3389/fpubh.2024.1416689
- By:
- Publication type:
- Article
Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample.
- Published in:
- International Journal of Clinical Pharmacy, 2021, v. 43, n. 4, p. 1055, doi. 10.1007/s11096-020-01217-8
- By:
- Publication type:
- Article
State-Level Approaches to Expanding Pharmacists' Authority to Dispense Naloxone May Affect Accessibility.
- Published in:
- 2019
- By:
- Publication type:
- letter
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA.
- Published in:
- Addiction, 2021, v. 116, n. 6, p. 1505, doi. 10.1111/add.15314
- By:
- Publication type:
- Article